Akari Therapeutics, Plc
AKTX
$0.92
-$0.005-0.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.27M | -17.93M | -19.79M | -20.16M | -20.13M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 14.00K | 14.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.00K | 1.76M | 686.00K | 117.00K | 601.00K |
| Change in Net Operating Assets | 3.04M | 5.51M | 6.54M | 5.19M | 3.72M |
| Cash from Operations | -9.02M | -10.66M | -12.55M | -14.84M | -15.80M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 382.00K | 382.00K | 382.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 382.00K | 382.00K | 382.00K | -- | -- |
| Total Debt Issued | 26.00K | 1.03M | 1.03M | 1.03M | 1.00M |
| Total Debt Repaid | -2.04M | -2.15M | -1.86M | -882.00K | -546.00K |
| Issuance of Common Stock | 9.04M | 12.87M | 11.95M | 12.34M | 12.34M |
| Repurchase of Common Stock | -136.00K | -136.00K | -136.00K | -136.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 330.00K | -- | -- | -- | -- |
| Cash from Financing | 7.23M | 11.61M | 10.99M | 12.35M | 12.79M |
| Foreign Exchange rate Adjustments | 7.00K | 1.00K | -4.00K | 1.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.41M | 1.33M | -1.19M | -2.49M | -3.00M |